Acura Pharmaceuticals, Inc. filed its 10-K on Jun 30, 2023 for the period ending Dec 31, 2021. In this report its auditor, , gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.01 USD | +257.14% | 0.00% | +9,900.00% |
1st Jan change | Capi. | |
---|---|---|
+9,900.00% | 663K | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- ACUR Stock
- News Acura Pharmaceuticals, Inc.
- Acura Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt